Anti-ACTL8 Antibody

This polyclonal antibody from Antibodies.com targets ACTL8 (Actin-Like 8), a cancer/testis antigen (CT51) family member linked to hepatocellular carcinoma proliferation, epithelial-mesenchymal transition, and tumor progression. Raised in rabbit and supplied as 100 µL of unconjugated antiserum, it is validated for Western blot and immunohistochemistry on human specimens, with reactivity demonstrated against the human ACTL8 protein. The polyclonal format recognizes multiple epitopes along the target, supporting robust signal in cell line lysates and patient-derived tissue sections used in oncology research workflows. Investigators studying CT-antigen expression profiles, HCC biomarkers, and actin-like cytoskeletal regulators rely on this reagent for chromogenic and chemiluminescent detection protocols. Aliquoting upon first use helps preserve activity across multiple experimental runs.